36 min listen
#75 What's Coming Next? Understanding the Next Big Areas in the Pharmaceutical Antitrust Wars
#75 What's Coming Next? Understanding the Next Big Areas in the Pharmaceutical Antitrust Wars
ratings:
Length:
43 minutes
Released:
Aug 24, 2020
Format:
Podcast episode
Description
Battles in the pharmaceutical antitrust world have been increasingly heated, and to a great extent rightly so, as people have devoted more attention to this space in the past decades. But as measured against the U.S. antitrust laws, what has changed or will change in the scrutiny of pharmaceutical companies’ conduct? Eric Grannon, a leading defense practitioner, joins Anora Wang and John Roberti to discuss three main areas—reverse payment, product hopping, and class certification—that get the most heat. Listen to this episode to learn what is about to come in the U.S. pharmaceutical antitrust wars. Related Links: Watson Pharmaceuticals, Inc., et al. (FTC v. Actavis) Hosted by: John Roberti, Allen & Overy LLP and Anora Wang, Winston & Strawn LLP
Released:
Aug 24, 2020
Format:
Podcast episode
Titles in the series (100)
#12 Who is Watching the Ads? The Biggest Mistakes Advertisers Make that Trigger Investigations.: Christopher A. Cole, Partner, Crowell & Moring LLP by Our Curious Amalgam